BR112017000606A2 - composto de macrolídeo c-4"-substituído - Google Patents

composto de macrolídeo c-4"-substituído

Info

Publication number
BR112017000606A2
BR112017000606A2 BR112017000606A BR112017000606A BR112017000606A2 BR 112017000606 A2 BR112017000606 A2 BR 112017000606A2 BR 112017000606 A BR112017000606 A BR 112017000606A BR 112017000606 A BR112017000606 A BR 112017000606A BR 112017000606 A2 BR112017000606 A2 BR 112017000606A2
Authority
BR
Brazil
Prior art keywords
macrolide compound
substituted macrolide
compound
resistant
mycoplasmas
Prior art date
Application number
BR112017000606A
Other languages
English (en)
Inventor
Hayashi Masato
Kawaguchi Takanori
Sugimoto Tomohiro
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of BR112017000606A2 publication Critical patent/BR112017000606A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

um composto da seguinte fórmula , que possui boa atividade microbiana contra bactérias resistentes à eritromicina, tais como pneumococos, estreptococos, micoplasmas resistentes, e similares, contra as quais antibióticos macrolídeos convencionais não possuem atividade antibacteriana suficiente. além disso, é fornecido um sal farmaceuticamente aceitável do mesmo, ou um hidrato ou um solvato do mesmo.
BR112017000606A 2014-08-18 2015-08-17 composto de macrolídeo c-4"-substituído BR112017000606A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014165848 2014-08-18
PCT/JP2015/072993 WO2016027755A1 (ja) 2014-08-18 2015-08-17 Ｃ－４"位置換マクロライド化合物

Publications (1)

Publication Number Publication Date
BR112017000606A2 true BR112017000606A2 (pt) 2017-11-07

Family

ID=55350700

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000606A BR112017000606A2 (pt) 2014-08-18 2015-08-17 composto de macrolídeo c-4"-substituído

Country Status (19)

Country Link
US (1) US20170267708A1 (pt)
EP (1) EP3192798A4 (pt)
JP (1) JP5874871B1 (pt)
KR (1) KR20170036106A (pt)
CN (1) CN106573953A (pt)
AR (1) AR102810A1 (pt)
AU (1) AU2015304439A1 (pt)
BR (1) BR112017000606A2 (pt)
CA (1) CA2957628A1 (pt)
CL (1) CL2017000395A1 (pt)
CO (1) CO2017002440A2 (pt)
IL (1) IL250559A0 (pt)
MX (1) MX2017002223A (pt)
PE (1) PE20170467A1 (pt)
PH (1) PH12017500223A1 (pt)
RU (1) RU2017108908A (pt)
SG (1) SG11201701146TA (pt)
TW (1) TW201625656A (pt)
WO (1) WO2016027755A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 Ｃ－４"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN114231430B (zh) * 2021-06-11 2024-02-09 常州大学 一种红霉素降解菌iurm f57及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54967A (en) 1977-06-06 1979-01-06 Mitsubishi Electric Corp Output circuit
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ATE296832T1 (de) 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
JP2014058507A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd １１位アミノ置換マクロライド誘導体
JP2014058508A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd ９位オキシム置換マクロライド誘導体

Also Published As

Publication number Publication date
EP3192798A4 (en) 2018-01-03
JPWO2016027755A1 (ja) 2017-04-27
MX2017002223A (es) 2017-05-09
WO2016027755A1 (ja) 2016-02-25
CL2017000395A1 (es) 2018-01-05
US20170267708A1 (en) 2017-09-21
IL250559A0 (en) 2017-03-30
RU2017108908A (ru) 2018-09-21
PE20170467A1 (es) 2017-04-26
JP5874871B1 (ja) 2016-03-02
AU2015304439A1 (en) 2017-03-16
KR20170036106A (ko) 2017-03-31
PH12017500223A1 (en) 2017-07-10
SG11201701146TA (en) 2017-03-30
TW201625656A (zh) 2016-07-16
CN106573953A (zh) 2017-04-19
EP3192798A1 (en) 2017-07-19
CA2957628A1 (en) 2016-02-25
AR102810A1 (es) 2017-03-29
CO2017002440A2 (es) 2017-04-28

Similar Documents

Publication Publication Date Title
MY161451A (en) C-4" position substituted macrolide derivative
MX2016011822A (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas.
BR112017027951A2 (pt) composto inibitório de brk
CL2016002918A1 (es) Compuestos derivados de quinazolina-4(3h)-ona-n-hidroxi-2-metil-2-metilsulfonil-butanamida; composicion farmaceutica; actividad antibacteriana gram-negativo.
BR112016027691A2 (pt) Composto de tetra-hidropiridopirimidina e seus usos
IL254457B (en) A combination of a bactericide and a lysosomotropic alkaline agent for the treatment of bacterial infection
BR112016017317A2 (pt) composto, antagonista de trpa1, medicamento, e, uso de um composto
EP3660245A4 (en) ANTIBACTERIAL DOOR KNOB
HK1254239A1 (zh) 有效對抗多藥耐藥細菌的新的氨基糖苷抗生素
MX2016010385A (es) Agentes antibacterianos.
BR112012030621A8 (pt) Compostos para o tratamento de doença associada a clostridium difficile
PL3448992T3 (pl) Środki przeciwdrobnoustrojowe na bakterie Salmonella
MY189098A (en) Heterobicyclic compounds and their use for the treatment of tuberculosis
PH12018500697A1 (en) Hydroxyalkyl thiadiazole derivatives
BR112017000606A2 (pt) composto de macrolídeo c-4"-substituído
EP3795915A4 (en) MALFUNCTIONING DIAGNOSIS SYSTEM
EP3592349A4 (en) ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS, FOR THE TREATMENT OF PSORIASIS
GB201718133D0 (en) Modified bacterial spores
ZA202001108B (en) Pct and pro-adm as markers for monitoring antibiotic treatment
EP3273797A4 (en) Composition inhibiting gram-positive, pathogenic bacteria
EP3664794A4 (en) LAURIC ACID DERIVATIVES WITH INHIBITORIC EFFECT AGAINST GRAMPOSITIVE AND / OR GRAMNEGATIVE ORGANISMS
EP3103460A4 (en) Bactericidal composition for bacterial skin disease
EP3522896A4 (en) KETOLID WITH ANTIBACTERIAL EFFECT
CL2018001242S1 (es) Puerta de control de acceso.
ES1220884Y (es) Sistema de guiado de puerta corredera frigorifica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]